Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:1748-1754
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wahab, N. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wahab, N. N.

CLINICAL STUDY: ACUTE CORONARY SYNDROMES

Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?

Nazneem N. Wahab, MD*, Elizabeth A. Cowden, MD{dagger}, Neil J. Pearce, MD*, Martin J. Gardner, MD*, Heather Merry, MSc*, Jafna L. Cox, MD*{ddagger},* ICONS Investigators

* Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada
{dagger} Division of Endocrinology, Dalhousie University, Halifax, Nova Scotia, Canada
{ddagger} Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada

Manuscript received April 18, 2002; revised manuscript received June 26, 2002, accepted July 24, 2002.

* Reprint requests and correspondence: Dr. Jafna L. Cox, Director of Health Services and Outcomes Research, Division of Cardiology, Queen Elizabeth II Health Sciences Centre, New Halifax Infirmary Site, Room 2147, 1796 Summer Street, Halifax, Nova Scotia B3H 3A7, Canada.
coxjl{at}is.dal.ca

OBJECTIVES: This study was designed to assess the prognostic significance of hyperglycemia in acute myocardial infarction (AMI) in the thrombolytic era using contemporary criteria for hyperglycemia.

BACKGROUND: Most studies that have examined this issue were performed before the widespread use of disease-modifying therapies and varied in their definition of hyperglycemia, assessment of risk factors, and reported outcomes.

METHODS: There were 1,664 consecutively hospitalized patients with AMI between October 1997 and October 1998 from a disease-specific, population-based registry. Patients were stratified according to history of diabetes mellitus and, further, according to whether they had a blood glucose >198 mg/dl (11 mmol/l). The influences of cardiac risk factors, medications, and interventions were analyzed, and multivariate logistic regression was used to determine the influence of blood glucose on mortality.

RESULTS: In patients without a history of diabetes, glucose levels were ≤198 mg/dl in 1,078 patients (Group 1) and >198 mg/dl in 135 (Group 2). Of those with diabetes, glucose levels were ≤198 mg/dl in 169 patients (Group 3) and >198 mg/dl in 282 (Group 4). Compared with Group 1 patients, the odds ratios (95% confidence interval) for in-hospital mortality among those in Groups 2, 3, and 4 were 2.44 (1.42 to 4.20; p = 0.001), 1.87 (1.05 to 3.34; p = 0.035), and 1.91 (1.16 to 3.14; p = 0.011), respectively. These groups also had greater 12-month mortality.

CONCLUSIONS: Hyperglycemia in AMI is associated with poor outcome even among patients without known diabetes. This finding underlines the need for aggressive glucose management in this setting and may support a more vigorous screening strategy for early recognition of diabetes.

Abbreviations and Acronyms
  AMI
  acute myocardial infarction
  CAD
  coronary artery disease
  CHF
  congestive heart failure
  ICONS
  Improving Cardiovascular Outcomes in Nova Scotia




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. Knapik, P. Nadziakiewicz, E. Urbanska, W. Saucha, M. Herdynska, and M. Zembala
Cardiopulmonary Bypass Increases Postoperative Glycemia and Insulin Consumption After Coronary Surgery.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1859 - 1865.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Anantharaman, M Heatley, and C F M Weston
Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
Heart, May 1, 2009; 95(9): 697 - 703.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. Kosiborod, S. E. Inzucchi, A. Goyal, H. M. Krumholz, F. A. Masoudi, L. Xiao, and J. A. Spertus
Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction
JAMA, April 15, 2009; 301(15): 1556 - 1564.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Kosiborod, S. E. Inzucchi, J. A. Spertus, Y. Wang, F. A. Masoudi, E. P. Havranek, and H. M. Krumholz
Elevated Admission Glucose and Mortality in Elderly Patients Hospitalized With Heart Failure
Circulation, April 14, 2009; 119(14): 1899 - 1907.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, F. A. Masoudi, A. Goyal, L. Xiao, P. G. Jones, S. Fiske, and J. A. Spertus
Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction
Arch Intern Med, March 9, 2009; 169(5): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Z. Yang, V. E. Laubach, B. A. French, and I. L. Kron
Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 723 - 729.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. R. Sinnaeve, P. G. Steg, K. A. A. Fox, F. Van de Werf, G. Montalescot, C. B. Granger, E. Knobel, F. A. Anderson, O. H. Dabbous, A. Avezum, et al.
Association of Elevated Fasting Glucose With Increased Short-term and 6-Month Mortality in ST-Segment Elevation and Non-ST-Segment Elevation Acute Coronary Syndromes: The Global Registry of Acute Coronary Events
Arch Intern Med, February 23, 2009; 169(4): 402 - 409.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Timmers, J. P.S. Henriques, D. P.V. de Kleijn, J. H. DeVries, H. Kemperman, P. Steendijk, C. W.J. Verlaan, M. Kerver, J. J. Piek, P. A. Doevendans, et al.
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
J. Am. Coll. Cardiol., February 10, 2009; 53(6): 501 - 510.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Ceriello, S. W. Zarich, and R. Testa
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S9 - 13.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty
Insulin as an anti-inflammatory and antiatherogenic modulator.
J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S14 - S20.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. E. Umpierrez, T. Hor, D. Smiley, A. Temponi, D. Umpierrez, M. Ceron, C. Munoz, C. Newton, L. Peng, and D. Baldwin
Comparison of Inpatient Insulin Regimens with Detemir plus Aspart Versus Neutral Protamine Hagedorn plus Regular in Medical Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 564 - 569.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
M. Kosiborod
Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction
Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 269 - 275.
[Abstract] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
A. Goyal, K. Nerenberg, H. C Gerstein, G. Umpierrez, and P. W. Wilson
Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points
Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 276 - 284.
[Abstract] [PDF]


Home page
Diabetes Spectr.Home page
M. C. Lansang and G. E. Umpierrez
Management of Inpatient Hyperglycemia in Noncritically Ill Patients
Diabetes Spectr, October 1, 2008; 21(4): 248 - 255.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Undas, I. Wiek, E. Stepien, K. Zmudka, and W. Tracz
Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
Diabetes Care, August 1, 2008; 31(8): 1590 - 1595.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Kloner and R. W. Nesto
Glucose-Insulin-Potassium for Acute Myocardial Infarction: Continuing Controversy Over Cardioprotection
Circulation, May 13, 2008; 117(19): 2523 - 2533.
[Full Text] [PDF]


Home page
CirculationHome page
P. Deedwania, M. Kosiborod, E. Barrett, A. Ceriello, W. Isley, T. Mazzone, and P. Raskin
Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism
Circulation, March 25, 2008; 117(12): 1610 - 1619.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. W. Nesto and R. M. Lago
Glucose: A Biomarker in Acute Myocardial Infarction Ready for Prime Time?
Circulation, February 26, 2008; 117(8): 990 - 992.
[Full Text] [PDF]


Home page
CirculationHome page
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, L. Xiao, P. G. Jones, S. Fiske, F. A. Masoudi, S. P. Marso, and J. A. Spertus
Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk
Circulation, February 26, 2008; 117(8): 1018 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
D. Mudespacher, D. Radovanovic, E. Camenzind, M. Essig, O. Bertel, P. Erne, F. R. Eberli, and F. Gutzwiller
Admission glycaemia and outcome in patients with acute coronary syndrome
Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 346 - 352.
[Abstract] [PDF]


Home page
CirculationHome page
S. W. Zarich and R. W. Nesto
Implications and Treatment of Acute Hyperglycemia in the Setting of Acute Myocardial Infarction
Circulation, May 8, 2007; 115(18): e436 - e439.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Ishihara, I. Inoue, T. Kawagoe, Y. Shimatani, S. Kurisu, T. Hata, Y. Nakama, Y. Kijima, and E. Kagawa
Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?
Eur. Heart J., October 2, 2006; 27(20): 2413 - 2419.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. W. A. Smit and J. A. Romijn
Acute insulin resistance in myocardial ischemia: causes and consequences.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 215 - 219.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
A. Barsheshet, M. Garty, E. Grossman, A. Sandach, B. S. Lewis, S. Gottlieb, A. Shotan, S. Behar, A. Caspi, R. Schwartz, et al.
Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure.
Arch Intern Med, August 14, 2006; 166(15): 1613 - 1619.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Goyal, K. W. Mahaffey, J. Garg, J. C. Nicolau, J. S. Hochman, W. D. Weaver, P. Theroux, G. B.F. Oliveira, T. G. Todaro, C. F. Mojcik, et al.
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
Eur. Heart J., June 1, 2006; 27(11): 1289 - 1297.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J.R. Timmer, J.P. Ottervanger, H.J.G. Bilo, J.H.E. Dambrink, K. Miedema, J.C.A. Hoorntje, and F. Zijlstra
Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes
QJM, April 1, 2006; 99(4): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Ellger, Y. Debaveye, I. Vanhorebeek, L. Langouche, A. Giulietti, E. Van Etten, P. Herijgers, C. Mathieu, and G. Van den Berghe
Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.
Diabetes, April 1, 2006; 55(4): 1096 - 1105.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
J.-P. Collet and G. Montalescot
The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes
Diabetes and Vascular Disease Research, October 1, 2005; 2(3): 136 - 143.
[Abstract] [PDF]


Home page
Eur Heart JHome page
A.-M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
Eur. Heart J., July 1, 2005; 26(13): 1255 - 1261.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Kosiborod, S. S. Rathore, S. E. Inzucchi, F. A. Masoudi, Y. Wang, E. P. Havranek, and H. M. Krumholz
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes
Circulation, June 14, 2005; 111(23): 3078 - 3086.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Zeller, P. G. Steg, J. Ravisy, Y. Laurent, L. Janin-Manificat, I. L'Huillier, J.-C. Beer, A. Oudot, G. Rioufol, H. Makki, et al.
Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction
Arch Intern Med, May 23, 2005; 165(10): 1192 - 1198.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. R. Timmer, J. P. Ottervanger, M.-J. de Boer, J.-H. E. Dambrink, J. C.A. Hoorntje, A.T. M. Gosselink, H. Suryapranata, F. Zijlstra, A. W.J. van't Hof, and Zwolle Myocardial Infarction Study Group
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 999 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. A. McAlister, S. R. Majumdar, S. Blitz, B. H. Rowe, J. Romney, and T. J. Marrie
The Relation Between Hyperglycemia and Outcomes in 2,471 Patients Admitted to the Hospital With Community-Acquired Pneumonia
Diabetes Care, April 1, 2005; 28(4): 810 - 815.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
T. M Conner, K. R Flesner-Gurley, and J. C Barner
Hyperglycemia in the Hospital Setting: The Case for Improved Control Among Non-Diabetics
Ann. Pharmacother., March 1, 2005; 39(3): 492 - 501.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Ceriello
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction
Eur. Heart J., February 2, 2005; 26(4): 328 - 331.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
The CREATE-ECLA Trial Group Investigators*
Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATE-ECLA Randomized Controlled Trial
JAMA, January 26, 2005; 293(4): 437 - 446.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ceriello
Insulin, Glycemic Control, and C-Reactive Protein During Myocardial Infarction
Diabetes Care, December 1, 2004; 27(12): 3017 - 3018.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Bartnik, K. Malmberg, A. Norhammar, A. Tenerz, J. Ohrvik, and L. Ryden
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction
Eur. Heart J., November 2, 2004; 25(22): 1990 - 1997.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Aguilar, S. D. Solomon, L. Kober, J.-L. Rouleau, H. Skali, J. J.V. McMurray, G. S. Francis, M. Henis, C. M. O'Connor, R. Diaz, et al.
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Circulation, September 21, 2004; 110(12): 1572 - 1578.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. M. Cely, P. Arora, A. A. Quartin, D. H. Kett, and R. M. H. Schein
Relationship of Baseline Glucose Homeostasis to Hyperglycemia During Medical Critical Illness
Chest, September 1, 2004; 126(3): 879 - 887.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Inpatient Diabetes Control: Rationale
Diabetes Care, August 1, 2004; 27(8): 2074 - 2080.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. S. Krinsley
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Mayo Clin. Proc., August 1, 2004; 79(8): 992 - 1000.
[Abstract] [PDF]


Home page
CirculationHome page
H. L. Lazar, S. R. Chipkin, C. A. Fitzgerald, Y. Bao, H. Cabral, and C. S. Apstein
Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events
Circulation, March 30, 2004; 109(12): 1497 - 1502.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. A. Goldberg, M. D. Siegel, R. S. Sherwin, J. I. Halickman, M. Lee, V. A. Bailey, S. L. Lee, J. D. Dziura, and S. E. Inzucchi
Implementation of a Safe and Effective Insulin Infusion Protocol in a Medical Intensive Care Unit
Diabetes Care, February 1, 2004; 27(2): 461 - 467.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Tenerz, A. Norhammar, A. Silveira, A. Hamsten, G. Nilsson, L. Ryden, and K. Malmberg
Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes
Diabetes Care, October 1, 2003; 26(10): 2770 - 2776.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. A. Brady and A. Jovanovic
The sulfonylurea controversy: Much ado about nothing or cause for concern?
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1022 - 1025.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Dandona, A. Aljada, A. Chaudhuri, and A. Bandyopadhyay
The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2422 - 2429.
[Full Text] [PDF]


Home page
Diabetes CareHome page
F. A. McAlister, J. Man, L. Bistritz, H. Amad, and P. Tandon
Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes
Diabetes Care, May 1, 2003; 26(5): 1518 - 1524.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement